Who cares what AF says, Misleading has not delivered, all trials have failed to achieve stat sig as per protocol. You are trying to put lipstick on pig
He picks on weak companies with questionable business practices as he sees it. He is often wrong .Like a Crammer. I have been on a winning side against him before. His influence is in a select short crowd. Until approval in US Fraudstein will bash. If you still believe we have a shot of approval you double down. I am given serious consideration to doubling or tripling down at 5. I keep thinking EMA . Who knows. Bio tech is like boxing pre FDA approval AVXL is not out and is still in the game.
News 
Market Data 
Discover 
